Femasys Inc. (FEMY)
USD 1.14
(5.56%)
USD 1.14
(5.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.7 Million USD | 1132.43% |
| 2022 | 543.71 Thousand USD | -45.09% |
| 2021 | 990.21 Thousand USD | -51.83% |
| 2020 | 2.05 Million USD | 20.14% |
| 2019 | 1.71 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7.06 Million USD | 2.81% |
| 2024 Q1 | 6.87 Million USD | 2.53% |
| 2023 FY | 6.7 Million USD | 1132.43% |
| 2023 Q2 | 209.09 Thousand USD | -31.46% |
| 2023 Q1 | 305.07 Thousand USD | -48.2% |
| 2023 Q4 | 6.7 Million USD | 134.09% |
| 2023 Q3 | 2.86 Million USD | 1268.99% |
| 2022 Q4 | 588.92 Thousand USD | -24.74% |
| 2022 Q2 | 1.02 Million USD | 35.95% |
| 2022 Q1 | 751.35 Thousand USD | -24.12% |
| 2022 FY | 543.71 Thousand USD | -45.09% |
| 2022 Q3 | 782.48 Thousand USD | -23.39% |
| 2021 Q1 | 1.98 Million USD | -3.4% |
| 2021 FY | 990.21 Thousand USD | -51.83% |
| 2021 Q4 | 990.21 Thousand USD | -19.87% |
| 2021 Q3 | 1.23 Million USD | -17.26% |
| 2021 Q2 | 1.49 Million USD | -24.79% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 2.05 Million USD | 0.0% |
| 2020 FY | 2.05 Million USD | 20.14% |
| 2019 FY | 1.71 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 92.182% |
| AngioDynamics, Inc. | 5.91 Million USD | -13.305% |
| AtriCure, Inc. | 74.49 Million USD | 91.005% |
| Avinger, Inc. | 15.39 Million USD | 56.474% |
| Azenta, Inc. | 60.43 Million USD | 88.912% |
| BioLife Solutions, Inc. | 42.69 Million USD | 84.304% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.739% |
| Daxor Corporation | 755.65 Thousand USD | -786.76% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | 6.517% |
| GlucoTrack, Inc. | 196 Thousand USD | -3318.817% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 84.334% |
| Hologic, Inc. | 2.53 Billion USD | 99.736% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.607% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 92.538% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -50.747% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 64.908% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.309% |
| Microbot Medical Inc. | 231 Thousand USD | -2800.815% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 8.597% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.248% |
| Nephros, Inc. | 1.83 Million USD | -264.972% |
| NovoCure Limited | 596.24 Million USD | 98.876% |
| NEXGEL, Inc. | 2.79 Million USD | -139.488% |
| NEXGEL, Inc. | 2.79 Million USD | -139.488% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 91.1% |
| OraSure Technologies, Inc. | 13.5 Million USD | 50.379% |
| Pro-Dex, Inc. | 13.54 Million USD | 50.536% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 26.718% |
| Predictive Oncology Inc. | 2.85 Million USD | -134.558% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -95.107% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.744% |
| Repligen Corporation | 711.8 Million USD | 99.059% |
| Sanara MedTech Inc. | 11.79 Million USD | 43.175% |
| STAAR Surgical Company | 35.83 Million USD | 81.3% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -1859.322% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.709% |
| Jin Medical International Ltd. | 4.11 Million USD | -62.92% |